1 |
Alves AM, Diel LF, Lamers ML. Macrophages and prognosis of oral squamous cell carcinoma: a systematic review[J]. J Oral Pathol Med, 2018, 47(5): 460-467.
|
2 |
Almangush A, Heikkinen I, Makitie AA, et al. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis[J]. Br J Cancer, 2017, 117(6): 856-866.
|
3 |
Feng Z, Xu QS, Qin LZ, et al. Predicting radiotherapy necessity in tongue cancer using lymph node yield[J]. J Oral Maxillofac Surg, 2017, 75(5): 1062-1070.
|
4 |
Sharma D, Singh G. Squamous cell carcinoma of the oral cavity and oropharynx in young adults[J]. Indian J Cancer, 2016, 53(3): 399-401.
|
5 |
Mohideen K, Krithika C, Jeddy N, et al. Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults[J]. J Oral Maxillofac Pathol, 2019, 23(3): 450-457.
|
6 |
Haga RB, Ridley AJ. Rho GTPases: regulation and roles in cancer cell biology[J]. Small GTPases, 2016, 7(4): 207-221.
|
7 |
Glomset JA, Farnsworth CC. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes[J]. Annu Rev Cell Biol, 1994, 10: 181-205.
|
8 |
Dai Q, Choy E, Chiu V, et al. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum[J]. J Biol Chem, 1998, 273(24): 15030-15034.
|
9 |
Chang KW, Kao SY, Wu YH, et al. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA[J]. Oral Oncol, 2013, 49(1): 27-33.
|
10 |
Liao YC, Ruan JW, Lua I, et al. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling[J]. Oncogene, 2012, 31(25): 3086-3097.
|
11 |
Yang X, Zheng F, Zhang S, et al. Loss of RhoA expression prevents proliferation and metastasis of SPCA1 lung cancer cells in vitro[J]. Biomed Pharmacother, 2015, 69: 361-366.
|
12 |
Yao J, Gao P, Xu Y, et al. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling[J]. Mol Med Rep, 2016, 14(3): 2534-2540.
|
13 |
Xu XT, Song QB, Yao Y, et al. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells[J]. Hepatogastroenterology, 2012, 59(120): 2523-2526.
|
14 |
Li XR, Wu W, Qian LY, et al. Underexpression of dele-ted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma[J]. BMC Cancer, 2008, 8: 205.
|
15 |
周峻, 何勇, 董绍忠, 等. RhoA小干扰RNA对舌癌细胞Tca8113增殖、侵袭影响的体外实验[J]. 中华口腔医学杂志, 2010, 45(9): 520-524.
|
|
Zhou J, He Y, Dong SZ, et al. Effects of RhoA siRNA on the proliferation, adhesion, migration and invasion of tongue squamous cell carcinoma Tca8113 cells in vitro[J]. Chin J Stomatol, 2010, 45(9): 520-524.
|
16 |
Yan G, Zou R, Chen Z, et al. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer[J]. Acta Biochim Biophys Sin, 2014, 46(8): 682-690.
|
17 |
严国鑫, 樊兵, 邹荣海, 等. 沉默RohA基因对舌鳞状细胞癌细胞增殖的影响[J]. 华西口腔医学杂志, 2016, 34(6): 620-625.
|
|
Yan GX, Fan B, Zou RH, et al. Effects of RhoA silen-cing on proliferation of tongue squamous cancer cells[J]. West China J Stomatol, 2016, 34(6): 620-625.
|
18 |
Winter-vann AM, Casey PJ. Post-prenylation-processing enzymes as new targets in oncogenesis[J]. Nat Rev Cancer, 2005, 5(5): 405-412.
|
19 |
Cushman I, Casey PJ. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration[J]. J Biol Chem, 2009, 284(41): 27964-27973.
|
20 |
Liu Q, Chen J, Fu B, et al. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation[J]. Biochem Biophys Res Commun, 2018, 501(2): 556-562.
|
21 |
Xu J, Zhu Y, Wang F, et al. ICMT contributes to hepatocellular carcinoma growth, survival, migration and chemoresistance via multiple oncogenic pathways[J]. Biochem Biophys Res Commun, 2019, 518(3): 584-589.
|
22 |
Pan Q, Liu R, Banu H, et al. Inhibition of isoprenylcys-teine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway[J]. Biomed Pharmacother, 2018, 99: 169-175.
|
23 |
Lau HY, Tang J, Casey PJ, et al. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms[J]. Oncogene, 2017, 36(27): 3934-3942.
|
24 |
Magkouta S, Pappas A, Moschos C, et al. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion[J]. Oncotarget, 2016, 7(15): 20249-20259.
|
25 |
Lau HY, Ramanujulu PM, Guo D, et al. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo[J]. Cancer Biol Ther, 2014, 15(9): 1280-1291.
|
26 |
Wang M, Hossain MS, Tan W, et al. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth[J]. Oncogene, 2010, 29(35): 4959-4970.
|
27 |
Bergo MO, Gavino BJ, Hong C, et al. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf[J]. J Clin Invest, 2004, 113(4): 539-550.
|
28 |
Manu KA, Chai TF, Teh JT, et al. Inhibition of isoprenylcysteine carboxylmethyltransferase induces cell-cycle arrest and apoptosis through p21 and p21-regulated BNIP3 induction in pancreatic cancer[J]. Mol Cancer Ther, 2017, 16(5): 914-923.
|
29 |
Bergo MO, Leung GK, Ambroziak P, et al. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells[J]. J Biol Chem, 2000, 275(23): 17605-17610.
|
30 |
Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1[J]. Science, 1995, 269(5228): 1270-1272.
|
31 |
Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1[J]. Nature, 1998, 394(6690): 295-299.
|
32 |
Wang H, Wang B, Liao Q, et al. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma[J]. FEBS Lett, 2014, 588(3): 503-508.
|
33 |
Zuckerbraun BS, Shapiro RA, Billiar TR, et al. RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cip1 expression[J]. Circulation, 2003, 108(7): 876-881.
|